Literature DB >> 27909494

Anemia: An Independent Predictor Of Adverse Outcomes In Older Patients With Atrial Fibrillation.

Ali N Ali1, Nandkishor V Athavale2, Ahmed H Abdelhafiz2.   

Abstract

Both anemia and atrial fibrillation are common in older people and their prevalence is age dependent which increases as population ages. Anemia, especially acute onset, predisposes to new onset atrial fibrillation which is likely to be mediated through inducing heart failure first and this predisposition seems to be potentiated by the presence of renal impairment. Anemia adds to the comorbidity burden of patients with atrial fibrillation and independently increases the risks of adverse outcomes such as increased hospitalization, mortality, bleeding and thromboembolic events. Early detection and correction of anemia in patients with atrial fibrillation may have a positive impact on reducing these adverse events.

Entities:  

Keywords:  Adverse Outcomes; Anemia; Atrial Fibrillation

Year:  2016        PMID: 27909494      PMCID: PMC5089469          DOI: 10.4022/jafib.1366

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  36 in total

Review 1.  Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.

Authors:  Yi-Da Tang; Stuart D Katz
Journal:  Circulation       Date:  2006-05-23       Impact factor: 29.690

2.  A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.

Authors:  F D R Hobbs; D A Fitzmaurice; J Mant; E Murray; S Jowett; S Bryan; J Raftery; M Davies; G Lip
Journal:  Health Technol Assess       Date:  2005-10       Impact factor: 4.014

3.  A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation.

Authors:  Shinya Suzuki; Koichi Sagara; Takayuki Otsuka; Shunsuke Matsuno; Ryuichi Funada; Tokuhisa Uejima; Yuji Oikawa; Junji Yajima; Akira Koike; Kazuyuki Nagashima; Hajime Kirigaya; Hitoshi Sawada; Tadanori Aizawa; Takeshi Yamashita
Journal:  Am J Cardiol       Date:  2012-05-22       Impact factor: 2.778

4.  Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

Authors:  Brian F Gage; Yan Yan; Paul E Milligan; Amy D Waterman; Robert Culverhouse; Michael W Rich; Martha J Radford
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

5.  Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.

Authors:  R J Beyth; L M Quinn; C S Landefeld
Journal:  Am J Med       Date:  1998-08       Impact factor: 4.965

Review 6.  Anemia, diabetes, and chronic kidney disease.

Authors:  Uzma Mehdi; Robert D Toto
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

7.  Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Mark J Sarnak; Hocine Tighiouart; Guruprasad Manjunath; Bonnie MacLeod; John Griffith; Deeb Salem; Andrew S Levey
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

8.  Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach.

Authors:  Ali Ali; Claire Bailey; Ahmed H Abdelhafiz
Journal:  Aging Dis       Date:  2012-06-21       Impact factor: 6.745

9.  Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study.

Authors:  Christine Benn Christiansen; Jonas Bjerring Olesen; Gunnar Gislason; Morten Lock-Hansen; Christian Torp-Pedersen
Journal:  BMJ Open       Date:  2013-01-24       Impact factor: 2.692

10.  Anemia as an Independent Predictor of Adverse Cardiac Outcomes in Patients with Atrial Fibrillation.

Authors:  Wen-Hsien Lee; Po-Chao Hsu; Chun-Yuan Chu; Hung-Hao Lee; Meng-Kuang Lee; Chee-Siong Lee; Hsueh-Wei Yen; Tsung-Hsien Lin; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu; Ho-Ming Su
Journal:  Int J Med Sci       Date:  2015-07-16       Impact factor: 3.738

View more
  3 in total

1.  'Enemy within': an interesting cause for anemia during warfarin therapy for atrial fibrillation.

Authors:  Anita Ann Sunny; Josy Vallipalam; Balakrishnan Ramasamy; Rajesh Shankar Iyer
Journal:  BMJ Case Rep       Date:  2019-07-26

Review 2.  Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Fabian Sanchis-Gomar
Journal:  World J Cardiol       Date:  2019-12-26

3.  Characteristics of warfarin under-prescription in older adults with atrial fibrillation.

Authors:  Sana Rashid; Maciej Tysarowski; Jorge Naranjo; Atharva Dhole; Luka Petrovic; Emad F Aziz
Journal:  Int J Cardiol Heart Vasc       Date:  2021-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.